Menaquinone as a potential target of antibacterial agents.

Atmika Paudel, Hiroshi Hamamoto, Suresh Panthee, Kazuhisa Sekimizu

Journal: Drug discoveries & therapeutics 2017;10(3):123-8

PMID: 27431268

Abstract

The current trend of increasing infections by multidrug-resistant pathogens requires the discovery of novel antimicrobial agents with new target and selective toxicity towards pathogens. Menaquinone is a component of electron transport chains in a majority of anaerobic bacteria and Gram-positive bacteria. Due to its exclusivity in bacteria, menaquinone is thought to be a potential target for development of therapeutically effective antibacterial agents without side effects. In this review, we summarize inhibitors of menaquinone biosynthesis and antibiotics directly targeting menaquinone in bacteria.

Address: Teikyo University Institute of Medical Mycology.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.